Showing 861 - 869 results of 869 for search '(( decrease wear resistance ) OR ( decrease ((near resistance) OR (heat resistance)) ))', query time: 0.28s Refine Results
  1. 861

    Blockade of ROMK currents by TPN-RQ and the lack of effect of Cys-to-Ser mutants. by Masayoshi Okada (288631)

    Published 2020
    “…The remaining current was resistant to 6 mM BaCl<sub>2</sub>, which is a selective blocker of the ROMK channel, indicating that TPN-RQ blocked the channel nearly completely. …”
  2. 862

    Oral administration of Huanglian-Houpo herbal nanoemulsion loading multiple phytochemicals for ulcerative colitis therapy in mice by Xiao Wang (19312)

    Published 2023
    “…The TEM morphology of HLHPEN shows the nearly spheroidal shape of particles. The optimized HLHPEN showed a brownish yellow milky single-phase and optimal physical stability at 25 °C for 90 days. …”
  3. 863

    Table 1_Antimicrobial peptide AMP-17 induces protection against systemic candidiasis and interacts synergistically with fluconazole against Candida albicans biofilm.docx by Chaoqin Sun (740804)

    Published 2024
    “…The emergence of drug-resistant fungal strains compels us to look for an efficient treatment solution. …”
  4. 864

    Image_2_Thermoresponsive Copolymer Nanovectors Improve the Bioavailability of Retrograde Inhibitors in the Treatment of Leishmania Infections.tif by Evan Craig (4025492)

    Published 2021
    “…Unfortunately, currently available anti-Leishmania drugs face several obstacles, including toxicity that limits dosing and emergent drug resistant strains in endemic regions. It is, therefore, imperative that more effective drug formulations with decreased toxicity profiles are developed. …”
  5. 865

    Image_3_Thermoresponsive Copolymer Nanovectors Improve the Bioavailability of Retrograde Inhibitors in the Treatment of Leishmania Infections.tif by Evan Craig (4025492)

    Published 2021
    “…Unfortunately, currently available anti-Leishmania drugs face several obstacles, including toxicity that limits dosing and emergent drug resistant strains in endemic regions. It is, therefore, imperative that more effective drug formulations with decreased toxicity profiles are developed. …”
  6. 866

    Image_4_Thermoresponsive Copolymer Nanovectors Improve the Bioavailability of Retrograde Inhibitors in the Treatment of Leishmania Infections.tif by Evan Craig (4025492)

    Published 2021
    “…Unfortunately, currently available anti-Leishmania drugs face several obstacles, including toxicity that limits dosing and emergent drug resistant strains in endemic regions. It is, therefore, imperative that more effective drug formulations with decreased toxicity profiles are developed. …”
  7. 867

    Image_1_Thermoresponsive Copolymer Nanovectors Improve the Bioavailability of Retrograde Inhibitors in the Treatment of Leishmania Infections.tif by Evan Craig (4025492)

    Published 2021
    “…Unfortunately, currently available anti-Leishmania drugs face several obstacles, including toxicity that limits dosing and emergent drug resistant strains in endemic regions. It is, therefore, imperative that more effective drug formulations with decreased toxicity profiles are developed. …”
  8. 868

    Data_Sheet_2_Conservation of Ancient Genetic Pathways for Intracellular Persistence Among Animal Pathogenic Bordetellae.xls by Israel Rivera (3471599)

    Published 2019
    “…These data show that the ability to persist inside macrophage-like RAW 264.7 cells is shared among nearly all Bordetella species, suggesting that resisting phagocytes may be an ancient mechanism that precedes speciation in the genus and may have facilitated the adaptation of Bordetella species from environmental bacteria to mammalian respiratory pathogens.…”
  9. 869

    Data_Sheet_1_Conservation of Ancient Genetic Pathways for Intracellular Persistence Among Animal Pathogenic Bordetellae.PDF by Israel Rivera (3471599)

    Published 2019
    “…These data show that the ability to persist inside macrophage-like RAW 264.7 cells is shared among nearly all Bordetella species, suggesting that resisting phagocytes may be an ancient mechanism that precedes speciation in the genus and may have facilitated the adaptation of Bordetella species from environmental bacteria to mammalian respiratory pathogens.…”